Summary
Updated Aug 30, 2026
Victor Sandor is Director of AbCellera Biologics Inc. (ABCL). 6 SEC Form 4 filings on record going back to 2025, most recently on 6 July 2026.
Recent Transactions
2Every recent SEC Form 4 transaction Victor Sandor has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Victor Sandor files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- BVF PARTNERS L P - $173.67M of KYMR open-market activity in the last 12 months
- BAKER BROS. ADVISORS LP - $172.50M of KYMR open-market activity in the last 12 months
- Bruce Booth - $100.59M of KYMR open-market activity in the last 12 months
- Nello Mainolfi - $34.88M of KYMR open-market activity in the last 12 months
- Jeremy G. Chadwick - $15.60M of KYMR open-market activity in the last 12 months
- Bruce N. Jacobs - $13.92M of KYMR open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Victor Sandor?
Victor Sandor is a corporate insider, tracked as Director of AbCellera Biologics Inc. (ABCL). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Victor Sandor submitted recently?
4 primary Form 4 filings in the last 90 days, covering 4 companies.
Where can I see all of Victor Sandor's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Victor Sandor and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
